[1] Schapher M, Mantsopoulos K, Messbacher ME, et al. Transoral submandibulotomy for deep hilar submandibular gland sialolithiasis [J]. Laryngoscope, 2017, 127(9):2038-2044. [2] Capaccio P, Gaffuri M, Rossi V, et al. Sialendoscope-assisted transoral removal of hilo-parenchymal sub-mandibular stones:surgical results and subjective scores [J]. Acta Otorhinolaryngologica Ital, 2017, 37(2):122-127. [3] Xiao JQ, Sun HJ, Qiao QH, et al. Advantages of submandibular gland preservation surgery over submandibular gland resection for proximal submandibular stones [J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2018, 125(5):e113-e117. [4] Kopeć T, Wierzbicka M, Kałuzny J, et al. Sialendoscopy and sialendoscopically-assisted operations in the treatment of lithiasis of the submandibular and parotid glands: our experience of 239 cases [J]. Br J Oral Maxillofac Surg, 2016, 54(7):767-771. [5] Laskawi R, Ellies M, Arglebe C, et al. Surgical management of benign tumors of the submandibular gland: a follow-up study [J]. J Oral maxillofac surg, 1995, 53(5):506-509. [6] Roh JL, Park CI. Gland-preserving surgery for pleomorphic adenoma in the submandibular gland [J]. Br J Surg, 2008, 95(10):1252-1256. [7] Ruan M, Zhang Z, Li SY, et al. Gland-preserving surgery can effectively preserve gland function without increased recurrence in treatment of benign submandibular gland tumour [J]. Br J Oral Maxillofac Surg, 2013, 51(7):615-619. [8] Ge N, Peng X, Zhang L et al. Partial sialoadenectomy for the treatment of benign tumours in the submandibular gland [J]. Int J Oral Maxillofac Surg, 2016, 45(6):750-755. [9] Byeon HK, Lim YC, Koo BS, et al. Metastasis to the submandibular gland in oral cavity squamous cell carcinomas: pathologic analysis [J]. Acta Otolaryngol, 2009, 129(1):96-100. [10] Naidu TK, Naidoo SK, Ramdial PK. Oral cavity squamous cell carcino mametastasis to the submandibular gland [J]. J Laryngol Otol, 2012, 126(3):279-284. [11] Malik A, Joshi P, Mishra A, et al. Prospective study of the pattern of lymphatic metastasis in relation to the submandibular gland in patients with carcinoma of the oral cavity [J]. Head Neck, 2016, 38(11):1703-1707. [12] Cakir Cetin A, Dogan E, Ozay H, et al. Submandibular gland invasion and feasibility of gland-spa ring neck dissection in oral cavity carcinoma [J]. J Laryngol Otol, 2018, 132(5):446-451. [13] Ashfaq K, Ashfaq M, Ahmed A, et al. Submandibular gland involvement in early stage oral cavity carcinomas: can the gland be left behind? [J]. J Coll Physicians Surg Pak, 2014, 24(8):565-568. [14] Sim C, Soong YL, Pang E, et al. Xerostomia, salivary characteristics and gland volumes following intensitymodulated radiotherapy for nasopharyngeal carcinoma: two year follow up [J]. Aust Dent J, 2018, 63(2):217-223. [15] Brodin NP, Kabarriti R, Pankuch M, et al. A quantitative clinical decisione-support strategy identifying which patients with oropharyngeal head and neck cancer nay benefit the most from proton radiation therapy [J]. Int J Radiat Oncol Biol Phys, 2019, 104(3):540-552. [16] Chuang TL, Wang YF, Tsai CH, et al. Evaluation of salivary function by sialoscintigraphy in locally advanced nasopharyngeal cancer patients after intensity modulated radiotherapy [J]. Indian J Cancer, 2015, 52(3):398-401. [17] Jackson WC, Hawkins PG, Arnould GS, et al. Submandibular gland sparing when irradiating neck level IB in the treatment of oral squamous cell carcinoma [J]. Med Dosim, 2019, 44(2):144-149. [18] Van Daele DJ, Langmore SE, Krisciunas GP, et al. The impact of time after radiation treatment on dysphagia in patients with head and neck cancer enrolled in a swallowing therapy program [J]. Head Neck, 2019, 41(3):606-614. [19] Seikaly H, Jha N, McGaw T, et al. Submandibular gland transfer: A new method of preventing radiation-induced Xerostomia [J]. Laryngoscope, 2001, 111(2):347-352. [20] Seikaly H, Jha N, Harris JR, et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia [J]. Arch Otolaryngol Head Neck Surg, 2004, 130(8):956-961. [21] Morand GB, Madana J, Da Silva SD, et al. Survival and quality of life in orophary ngeal cancer patients treated with primary chemoradiation after salivary gland transfer [J]. J Laryngol Otol, 2016, 130(8):755-762. [22] Scrimger RA, Seikaly H, Vos LJ, et al. Combination of submandibular salivary gland transfer and intensity-modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck cancer [J]. Head Neck, 2018, 40(11):2353-2361. |